Moleculin Biotech announces the issue of Canadian patent covered Anamycin
Moleculin Biotech (MBRX) has announced that the Canadian Intellectual Property Office, CIPO, has issued a notification of allowance for patent application no. 3.142.510 entitled: “Preparation …